Cisen Pharmaceutical disclosed its semi-annual report for 2026, with net profit attributable to the parent company reaching 264 million yuan in the first half, up 15.40% year on year. Total operating revenue for the same period was 1.693 billion yuan, down 2.68% year on year. Net profit excluding non-recurring items was 158 million yuan, down 12.00% year on year. Net cash flow from operating activities was 427 million yuan, up 20.88% year on year. The company plans to distribute a cash dividend of 2.16 yuan per 10 shares, tax included, to all shareholders.
Cisen Pharmaceutical Co LtdNet profit up 15.4% and dividend announced
